Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Neuregulin 2 antibody (AA 116-215)

This anti-Neuregulin 2 antibody is a Mouse Polyclonal antibody detecting Neuregulin 2 in WB and ELISA. Suitable for Human.
Catalog No. ABIN564117

Quick Overview for Neuregulin 2 antibody (AA 116-215) (ABIN564117)

Target

See all Neuregulin 2 (NRG2) Antibodies
Neuregulin 2 (NRG2)

Reactivity

  • 36
  • 11
  • 5
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 37
  • 5
Mouse

Clonality

  • 37
  • 5
Polyclonal

Conjugate

  • 23
  • 6
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This Neuregulin 2 antibody is un-conjugated

Application

  • 25
  • 23
  • 17
  • 9
  • 9
  • 4
  • 3
  • 2
Western Blotting (WB), ELISA
  • Binding Specificity

    • 8
    • 6
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 116-215

    Purpose

    Mouse polyclonal antibody raised against a partial recombinant NRG2.

    Sequence

    SLKSVQDQAY KAPVVVEGKV QGLVPAGGSS SNSTREPPAS GRVALVKVLD KWPLRSGGLQ REQVISVGSC VPLERNQRYI FFLEPTEQPL VFKTAFAPLD

    Cross-Reactivity

    Human

    Characteristics

    Antibody Reactive Against Recombinant Protein.

    Immunogen

    NRG2 (NP_004874, 116 a.a. ~ 215 a.a) partial recombinant protein with GST tag.
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    50 % glycerol

    Handling Advice

    Aliquot to avoid repeated freezing and thawing.

    Storage

    -20 °C

    Storage Comment

    Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
  • Target

    Neuregulin 2 (NRG2)

    Alternative Name

    NRG2

    Background

    Full Gene Name: neuregulin 2
    Synonyms: Don-1,HRG2,NTAK

    Gene ID

    9542

    NCBI Accession

    NM_004883

    Pathways

    RTK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway
You are here:
Chat with us!